JP2013514302A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514302A5
JP2013514302A5 JP2012543668A JP2012543668A JP2013514302A5 JP 2013514302 A5 JP2013514302 A5 JP 2013514302A5 JP 2012543668 A JP2012543668 A JP 2012543668A JP 2012543668 A JP2012543668 A JP 2012543668A JP 2013514302 A5 JP2013514302 A5 JP 2013514302A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
ring
cycloalkyl
groups selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013514302A (ja
JP5658272B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/069550 external-priority patent/WO2011073155A1/en
Publication of JP2013514302A publication Critical patent/JP2013514302A/ja
Publication of JP2013514302A5 publication Critical patent/JP2013514302A5/ja
Application granted granted Critical
Publication of JP5658272B2 publication Critical patent/JP5658272B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543668A 2009-12-17 2010-12-13 Ccr2の新規アンタゴニスト及びこれらの使用 Active JP5658272B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09179567 2009-12-17
EP09179567.4 2009-12-17
EP10162624 2010-05-12
EP10162624.0 2010-05-12
PCT/EP2010/069550 WO2011073155A1 (en) 2009-12-17 2010-12-13 Novel antagonists for ccr2 and uses thereof

Publications (3)

Publication Number Publication Date
JP2013514302A JP2013514302A (ja) 2013-04-25
JP2013514302A5 true JP2013514302A5 (cg-RX-API-DMAC7.html) 2014-11-06
JP5658272B2 JP5658272B2 (ja) 2015-01-21

Family

ID=43532680

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543668A Active JP5658272B2 (ja) 2009-12-17 2010-12-13 Ccr2の新規アンタゴニスト及びこれらの使用

Country Status (4)

Country Link
US (1) US20130143905A1 (cg-RX-API-DMAC7.html)
EP (1) EP2513086B1 (cg-RX-API-DMAC7.html)
JP (1) JP5658272B2 (cg-RX-API-DMAC7.html)
WO (1) WO2011073155A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687931C (en) 2007-05-31 2016-05-24 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists and uses thereof
ES2551557T3 (es) 2008-12-19 2015-11-19 Boehringer Ingelheim International Gmbh Pirimidin-4-carboxamidas cíclicas como antagonistas del receptor CCR2 para el tratamiento de inflamaciones, asma y EPOC
PL2513093T3 (pl) 2009-12-17 2015-03-31 Centrexion Therapeutics Corp Nowi antagoniści receptora CCR2 i ich zastosowanie
EP2569295B1 (en) 2010-05-12 2014-11-19 Boehringer Ingelheim International GmbH New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
WO2011141474A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2571870B1 (en) 2010-05-17 2015-01-21 Boehringer Ingelheim International GmbH Ccr2 antagonists and uses thereof
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
JP5721242B2 (ja) 2010-06-01 2015-05-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ccr2アンタゴニスト
JP5786258B2 (ja) * 2011-07-15 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規かつ選択的なccr2拮抗薬
CA2852160A1 (en) 2011-10-28 2013-05-02 Galderma Research & Development New leukocyte infiltrate markers for rosacea and uses thereof
CN104086539A (zh) * 2014-07-17 2014-10-08 天津炜捷制药有限公司 一种利伐沙班的制备方法
MX383744B (es) 2015-07-02 2025-03-14 Centrexion Therapeutics Corp Citrato de (4-((3r,4r)-3-metoxitetrahidro-piran-4-ilamino)piperidin-1-il) (5-metil-6-(((2r, 6s)-6-(p-tolil)tetrahidro-2h-piran-2-il) metilamino) pirimidin-4-il) metanona.
CN114349728A (zh) * 2020-10-12 2022-04-15 南京药石科技股份有限公司 (3r,4r)-4-氨基四氢吡喃-3-醇及其盐的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286641B6 (sk) * 1999-05-04 2009-03-05 Schering Corporation Piperazínové deriváty užitočné ako CCR5 antagonisty, farmaceutické prípravky s ich obsahom a ich použitie
GB0004153D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
AU2002214996B2 (en) 2000-10-12 2007-03-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AR035700A1 (es) 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
CA2450961C (en) 2001-06-22 2010-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
AU2002363236A1 (en) * 2001-10-30 2003-05-12 Millennium Pharmaceuticals, Inc. Compounds, pharmaceutical compositions and methods of use therefor
SE0203304D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Coumpounds
WO2004074438A2 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Ccr8 antagonists
AU2005259983B2 (en) * 2004-06-28 2011-07-28 Incyte Corporation 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MX2010003621A (es) * 2007-10-01 2010-04-14 Hoffmann La Roche N-heterociclil biaril carboxamidas como antagonistas del receptor ccr.
WO2009047161A1 (en) 2007-10-09 2009-04-16 F. Hoffmann-La Roche Ag Chiral cis-imidazolines
ES2551557T3 (es) * 2008-12-19 2015-11-19 Boehringer Ingelheim International Gmbh Pirimidin-4-carboxamidas cíclicas como antagonistas del receptor CCR2 para el tratamiento de inflamaciones, asma y EPOC

Similar Documents

Publication Publication Date Title
JP2013526554A5 (cg-RX-API-DMAC7.html)
CN107485612B (zh) 咪唑并吡啶化合物及其用途
JP7635206B2 (ja) Cftrモジュレータの作製プロセス
AU2022287625A1 (en) Inhibitors of short-chain dehydrogenase activity for treating fibrosis
JP5244863B2 (ja) ジオキサン−2−アルキルカルバメート誘導体の製造法およびその中間体
JP2013530953A5 (cg-RX-API-DMAC7.html)
JP2013526596A5 (cg-RX-API-DMAC7.html)
US20090099169A1 (en) Benzofuran Compounds As EP1 Receptor Antagonists
JP2015057388A (ja) S1p受容体モジュレーターおよびそれらの使用
HU228594B1 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
KR20120098796A (ko) 치료적 유용성을 지니는 수용체 조절제로서의 신규한 화합물
US20110028508A1 (en) Novel process for the preparation of scopine esters
JP2009532417A5 (cg-RX-API-DMAC7.html)
AU2009278306A1 (en) Quinuclidine carbonate derivatives and medicinal composition thereof
JP2008543860A5 (cg-RX-API-DMAC7.html)
JPH08503923A (ja) 7−(2−アミノエチル)−ベンゾチアゾロン
JP2022515755A (ja) 網膜疾患用化合物
JP2023513373A (ja) P2x3修飾薬
WO2004083193A1 (ja) アミド化合物およびこれを含有する殺菌剤組成物
JP2007509104A (ja) 複素環式化合物
KR102887518B1 (ko) Il-17 및 ror감마의 저해를 위한 피라졸 및 이미다졸 화합물
JP2001511792A (ja) 置換(1,3−ビス(シクロヘキシルメチル)−1,2,3,6−テトラヒドロ−2,6−ジオキソ−9h−プリン−8−イル)フェニル誘導体、それらの調製、および炎症性疾患および免疫疾患の治療におけるそれらの使用
KR20170023798A (ko) 디피콜릴아민 유도체 및 이들의 약제학적 용도
KR102295416B1 (ko) 1-(피페라진-1-일)-2-([1,2,4]트리아졸-1-일)-에타논 유도체
JP2009508911A (ja) 炎症疾患治療のためのピリミジン化合物